|
gptkbp:instanceOf
|
organization
|
|
gptkbp:acquisition
|
gptkb:Green_Cross_Health
Korea_Vaccine
|
|
gptkbp:awards
|
various industry awards
|
|
gptkbp:clinicalTrials
|
ongoing
|
|
gptkbp:collaborations
|
government agencies
academic institutions
|
|
gptkbp:employees
|
over 1,000
|
|
gptkbp:facilities
|
gptkb:Osaka
gptkb:Seoul
|
|
gptkbp:founded
|
1993
|
|
gptkbp:founder
|
gptkb:Yoshinori_Nishikawa
|
|
gptkbp:headCoach
|
CEO
|
|
gptkbp:headquarters
|
gptkb:Seoul,_South_Korea
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Green Cross
|
|
gptkbp:industry
|
biotechnology
|
|
gptkbp:innovation
|
gene therapy
biopharmaceuticals
cell therapy
|
|
gptkbp:market
|
global
|
|
gptkbp:partnerships
|
WHO
various hospitals
|
|
gptkbp:philanthropy
|
environmental protection
disaster relief
healthcare_initiatives
|
|
gptkbp:products
|
vaccines
blood products
diagnostic reagents
|
|
gptkbp:research_focus
|
cancer
autoimmune diseases
infectious diseases
|
|
gptkbp:revenue
|
over $500 million
|
|
gptkbp:stockExchange
|
gptkb:KOSDAQ
|
|
gptkbp:subsidiary
|
gptkb:Green_Cross_Holdings
Green_Cross_Lab.
|
|
gptkbp:sustainability
|
environmental initiatives
renewable energy
green technology
|
|
gptkbp:type
|
public company
|
|
gptkbp:website
|
www.greencross.com
|